{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:56:09Z","timestamp":1791276969585,"version":"4.1.0"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA09457"],"award-info":[{"award-number":["DA09457"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["MH81177"],"award-info":[{"award-number":["MH81177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Affairs Medical Research Service"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.neuropharm.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T20:31:22Z","timestamp":1424291482000},"page":"274-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"special_numbering":"PB","title":["The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function"],"prefix":"10.1016","volume":"96","author":[{"given":"Melissa L.","family":"Sinkus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Graw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-5255","authenticated-orcid":false,"given":"Henry A.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.02.006_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-3806(02)00547-3","article-title":"Development of the alpha 7 nicotinic cholinergic receptor in rat hippocampal formation","volume":"139","author":"Adams","year":"2002","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib2","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1164\/ajrccm.149.6.7911710","article-title":"Determinants of susceptibility to cigarette smoke. Potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodeling, and chronic airflow obstruction","volume":"149","author":"Aguayo","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0896-6273(94)90257-7","article-title":"Identification of acetylcholine-receptor channel-lining residues in the entire M2 segment of the alpha-subunit","volume":"13","author":"Akabas","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.1384130","article-title":"Acetylcholine-receptor channel structure probed in cysteine-substitution mutants","volume":"258","author":"Akabas","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of alpha 7 nicotinic acetylcholine receptors in the brain: facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mp.2009.42","article-title":"Genome-wide linkage in Utah autism pedigrees","volume":"15","author":"Allen-Brady","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/YPG.0b013e32833a9b7a","article-title":"Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia","volume":"20","author":"Ancin","year":"2010","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jad.2011.04.008","article-title":"CHRNA7 haplotypes are associated with impaired attention in euthymic bipolar disorder","volume":"133","author":"Ancin","year":"2011","journal-title":"J.\u00a0Affect. Dis."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0447.2009.01532.x","article-title":"Sustained attention as a potential endophenotype for bipolar disorder","volume":"122","author":"Ancin","year":"2010","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib11","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1523\/JNEUROSCI.20-16-06106.2000","article-title":"A\u00a0critical period for nicotine-induced disruption of synaptic development in rat auditory cortex","volume":"20","author":"Aramakis","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bcp.2011.06.018","article-title":"The duplicated alpha 7 nicotinic receptor gene CHRFAM7A is a dominant negative regulator of CHRNA7 expression","volume":"82","author":"Araud","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archgenpsychiatry.2010.114","article-title":"Altered expression of regulators of the cortical chloride transporters NRCC1 and KCC2 in schizophrenia","volume":"68","author":"Arion","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib14","first-page":"74","article-title":"Expression of the \u03b17 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS","volume":"230","author":"Benfante","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib15","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/S0028-3908(00)00153-2","article-title":"[3H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day","volume":"39","author":"Benhammou","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib16","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1523\/JNEUROSCI.18-17-06871.1998","article-title":"Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells","volume":"18","author":"Berger","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1124\/mol.107.042820","article-title":"Positive allosteric modulation of the alpha 7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment","volume":"74","author":"Bertrand","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib18","first-page":"3751","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(02)07340-3","article-title":"Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy","volume":"359","author":"Boer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X","article-title":"Comparison of the regional expression of nicotinic acetylcholine receptor \u03b17 mRNA and [125I]-\u03b1-bungarotoxin binding in human postmortem brain","volume":"387","author":"Breese","year":"1997","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)36798-9","article-title":"Effect of smoking history on [3H]nicotine binding in human postmortem brain","volume":"282","author":"Breese","year":"1997","journal-title":"J.\u00a0Pharm. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1017\/S1461145712001022","article-title":"Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers","volume":"16","author":"Brody","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-4522(94)00623-D","article-title":"Developmental expression of alpha 7 neuronal nicotinic receptor messenger RNA in rat sensory cortex and thalamus","volume":"67","author":"Broide","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib25","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1046\/j.1471-4159.1997.68062412.x","article-title":"Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes","volume":"68","author":"Bullock","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12031-011-9663-7","article-title":"DNA methylation and tissue-specific transcription of the \u03b17 nicotinic receptor gene (CHRNA7)","volume":"47","author":"Canastar","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12017-008-8048-8","article-title":"Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease","volume":"10","author":"Carson","year":"2008","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jmg.2007.052704","article-title":"The alpha 7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease","volume":"45","author":"Carson","year":"2008","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1471-4159.2007.05169.x","article-title":"Molecular characterization and localization of the RIC-3 protein, an effector of nicotinic acetylcholine receptor expression","volume":"105","author":"Castelan","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jnr.10550","article-title":"Involvement of the alpha 7 subunit of the nicotinic receptor in morphogenic and trophic effects of acetylcholine on embryonic rat spinal motoneurons in culture","volume":"72","author":"Catone","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib31","doi-asserted-by":"crossref","first-page":"40207","DOI":"10.1074\/jbc.R112.407668","article-title":"The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily","volume":"287","author":"Changeux","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1523\/JNEUROSCI.2973-13.2014","article-title":"Presynaptic alpha 7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation","volume":"34","author":"Cheng","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib33","doi-asserted-by":"crossref","first-page":"C903","DOI":"10.1152\/ajpcell.00216.2010","article-title":"Upregulation of nuclear factor-kappa B expression by SLURP-1 is mediated by alpha(7)-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases","volume":"299","author":"Chernyavsky","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-4159.2010.06845.x","article-title":"Repeated administration of alpha 7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha 7 nAChR levels in the brain","volume":"114","author":"Christensen","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0896-6273(00)80741-2","article-title":"Mutational analysis of the charge selectivity filter of the alpha 7 nicotinic acetylcholine receptor","volume":"22","author":"Corringer","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-3806(93)90085-O","article-title":"Regional patterns of cholinergic and glutamate activity in the developing and aging human brain","volume":"74","author":"Court","year":"1993","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00019442-200506000-00004","article-title":"A\u00a0cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease","volume":"13","author":"Craig","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<109::AID-AJMG1>3.0.CO;2-3","article-title":"No evidence for linkage between schizophrenia and markers at chromosome 15q13-14","volume":"88","author":"Curtis","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(00)00003-0","article-title":"Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas","volume":"393","author":"Dani","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","article-title":"The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation","volume":"151","author":"de Jonge","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1074\/jbc.M110.180067","article-title":"Function of partially duplicated human alpha 7 nicotinic receptor subunit CHRFAM7A Gene: potential implications for the cholinergic anti-inflammatory response","volume":"286","author":"de Lucas-Cerrillo","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib44","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1176\/ajp.2006.163.10.1832","article-title":"Episodic memory performance predicted by the 2bp deletion in exon 6 of the \u201calpha 7-like\u201d nicotinic receptor subunit gene","volume":"163","author":"Dempster","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pnpbp.2014.05.011","article-title":"Targeting the alpha(7) nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome","volume":"54","author":"Deutsch","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.108.046623","article-title":"Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms","volume":"74","author":"Dickinson","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuron.2012.07.026","article-title":"Unreliable evoked responses in autism","volume":"75","author":"Dinstein","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/mol.107.039180","article-title":"Subcellular trafficking, pentameric assembly, and subunit stoichiometry of neuronal nicotinic acetylcholine receptors containing fluorescently labeled alpha 6 and beta 3 subunits","volume":"73","author":"Drenan","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bcp.2009.05.023","article-title":"The nicotinic receptor of cochlear hair cells: a possible pharmacotherapeutic target?","volume":"78","author":"Elgoyhen","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000077543","article-title":"A\u00a0novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families","volume":"57","author":"Faraone","year":"2004","journal-title":"Hum. Hered."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib52","doi-asserted-by":"crossref","first-page":"42123","DOI":"10.1074\/jbc.M111.276014","article-title":"Transcriptional repression of the alpha 7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by Activating Protein-2 alpha (AP-2 alpha)","volume":"286","author":"Finlay-Schultz","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajmg.b.30306","article-title":"Association study of CHRFAM7A copy number and 2bp deletion polymorphisms with schizophrenia and bipolar affective disorder","volume":"141B","author":"Flomen","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsych. Gen."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib54","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ejhg.2008.112","article-title":"The copy number variant involving part of the alpha 7 nicotinic receptor gene contains a polymorphic inversion","volume":"16","author":"Flomen","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ejhg.2012.81","article-title":"Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 gating","volume":"21","author":"Flomen","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib56","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1523\/JNEUROSCI.18-04-01187.1998","article-title":"Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells","volume":"18","author":"Frazier","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib57","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2007.07020326","article-title":"Exacerbation of schizophrenia by varenicline","volume":"164","author":"Freedman","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib60","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ajmg.10100","article-title":"Evidence for the multigenic inheritance of schizophrenia","volume":"105","author":"Freedman","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib61","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","article-title":"Initial phase 2 trial of a nicotinic agonist in schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1471-4159.1999.0721117.x","article-title":"Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function","volume":"72","author":"Fryer","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)37928-5","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajmg.b.20061","article-title":"Comparison of polymorphisms in the \u03b17 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects","volume":"123","author":"Gault","year":"2003","journal-title":"Am. J. Med. Genet. B"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/geno.1998.5363","article-title":"Genomic organization and partial duplication of the human \u03b17 neuronal nicotinic acetylcholine receptor gene","volume":"52","author":"Gault","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib66","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajmg.1552","article-title":"Linkage analysis of schizophrenia to chromosome 15","volume":"105","author":"Gejman","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib67","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bcp.2007.05.023","article-title":"Heterogeneity and complexity of native brain nicotinic receptors","volume":"74","author":"Gotti","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-3057(95)00157-R","article-title":"Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity","volume":"52","author":"Grun","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib69","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/00001756-199906030-00028","article-title":"Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain","volume":"10","author":"Guan","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/mp.2013.30","article-title":"Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"19","author":"Guillozet-Bongaarts","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-4328(00)00210-2","article-title":"Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging","volume":"113","author":"Hellstrom-Lindahl","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2015.01.022","article-title":"Inside-out neuropharmacology of nicotinic drugs","volume":"96","author":"Henderson","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib73","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2003.10.043","article-title":"Association study of the human partially duplicated alpha 7 nicotinic acetylcholine receptor genetic variant with bipolar disorder","volume":"355","author":"Hong","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib75","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1523\/JNEUROSCI.3661-06.2007","article-title":"Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers","volume":"27","author":"Hope","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib76","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1006\/mcne.2002.1202","article-title":"Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways","volume":"21","author":"Hu","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/WNR.0b013e3282f35823","article-title":"Reliability of P50 auditory sensory gating measures in infants during active sleep","volume":"19","author":"Hunter","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib78","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0896-6273(02)00632-3","article-title":"Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1","volume":"33","author":"Ibanez-Tallon","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neures.2006.10.002","article-title":"Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophrenia","volume":"57","author":"Iwata","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib80","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1523\/JNEUROSCI.3009-04.2004","article-title":"Precise localization of alpha 7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area","volume":"24","author":"Jones","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W","article-title":"NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees","volume":"81","author":"Kaufmann","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2004.12.016","article-title":"Tropisetron improves deficits in auditory P50 suppression in schizophrenia","volume":"76","author":"Koike","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib83","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1124\/mol.105.012419","article-title":"Nicotine acts as a pharmacological chaperone to up-regulate human alpha 4 beta 2 acetylcholine receptors","volume":"68","author":"Kuryatov","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000054859","article-title":"Association study of a nicotinic receptor variant with schizophrenic disorders","volume":"43","author":"Lai","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib85","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1242\/jcs.137604","article-title":"Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility","volume":"127","author":"Lang","year":"2014","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le Novere","year":"2002","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainresbull.2012.11.003","article-title":"Alpha 7 Nicotinic acetylcholine receptors and their role in cognition","volume":"93","author":"Lendvai","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib88","series-title":"Nicotinic Receptors","first-page":"417","article-title":"Nicotinic receptors and mental illness","author":"Leonard","year":"2014"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib89","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0091-3057(01)00677-3","article-title":"Smoking and mental illness","volume":"70","author":"Leonard","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14622200110050213","article-title":"Neuronal nicotinic receptors: from structure to function","volume":"3","author":"Leonard","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib91","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.59.12.1085","article-title":"Association of promoter variants in the alpha 7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia","volume":"59","author":"Leonard","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1208\/s12248-009-9090-7","article-title":"Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry: implications for drug discovery","volume":"11","author":"Lester","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bcp.2013.07.021","article-title":"Complex relationships of nicotinic receptor actions and cognitive functions","volume":"86","author":"Levin","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib94","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1523\/JNEUROSCI.22-12-05001.2002","article-title":"alpha 7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex","volume":"22","author":"Levy","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib95","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20121270","article-title":"The \u03b17nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking","volume":"209","author":"Li","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease","volume":"15","author":"Lindstrom","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib97","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ajmg.1547","article-title":"Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families","volume":"105","author":"Liu","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib98","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.3952-08.2009","article-title":"A\u00a0novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides","volume":"29","author":"Liu","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib99","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1523\/JNEUROSCI.3235-12.2013","article-title":"A\u00a0novel nicotinic mechanism underlies beta-amyloid-induced neuronal hyperexcitation","volume":"33","author":"Liu","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib100","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.1134246","article-title":"Sequential interplay of nicotinic and GABAergic signaling guides neuronal development","volume":"314","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000080804","article-title":"Molecular evolution of the human chromosome 15 pericentromeric region","volume":"108","author":"Locke","year":"2005","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6976.1994.tb00067.x","article-title":"Adaptation of Escherichia coli to high osmolarity environments: osmoregulation of the high-affinity glycine betaine transport system proU","volume":"14","author":"Lucht","year":"1994","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-081X(199804)19:3<147::AID-BDD77>3.0.CO;2-9","article-title":"Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition","volume":"19","author":"Mahnir","year":"1998","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib104","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0026-895X(25)15183-3","article-title":"Characterization of nicotine binding in mouse brain and comparison with the binding of \u03b1-bungarotoxin and quinuclidinyl benzilate","volume":"22","author":"Marks","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(25)10395-7","article-title":"Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine and \u03b1-bungarotoxin binding","volume":"30","author":"Marks","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib106","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ajmg.b.30470","article-title":"Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type","volume":"144B","author":"Martin","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0891-0618(01)00117-X","article-title":"Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia","volume":"22","author":"Marutle","year":"2001","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0004.2010.01374.x","article-title":"Delineation of 15q13.3 microdeletions","volume":"78","author":"Masurel-Paulet","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib109","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/hmg\/ddm253","article-title":"Alpha 7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1","volume":"16","author":"Mathew","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib111","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib112","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic-drugs on the basis of dopamine D-1, D-2 and serotonin 2 PKI values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib113","first-page":"810","article-title":"Chromosome 15 duplicons mediate both Class I and Class II common deletions of Prader-Willi and Angelman syndrome patients","volume":"69","author":"Mewborn","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib114","first-page":"736","article-title":"Breakpoint junction fragments in Prader-Willi and Angelman syndrome (PWS\/AS) deletion patients reveal variable breakpoints within large duplicons","volume":"71","author":"Mewborn","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12031-009-9233-4","article-title":"Differential regulation of alpha 7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers","volume":"40","author":"Mexal","year":"2010","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib116","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molbrainres.2005.06.006","article-title":"Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers","volume":"139","author":"Mexal","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib117","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha 4 beta 2 and a full agonist at alpha 7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib118","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jmg.2008.059907","article-title":"Microdeletion\/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders","volume":"46","author":"Miller","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib119","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib120","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1523\/JNEUROSCI.1423-13.2014","article-title":"Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia","volume":"34","author":"Morita","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2012.12.025","article-title":"Dendritic spine alterations in the hippocampus and parietal cortex of alpha7 nicotinic acetylcholine receptor knockout mice","volume":"233","author":"Morley","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mol.111.074088","article-title":"\u03b17\u03b22 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their \u03b17-\u03b17 interfaces","volume":"81","author":"Murray","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib123","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/genetics\/156.1.297","article-title":"Estimate of the mutation rate per nucleotide in humans","volume":"156","author":"Nachman","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib124","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-3223(95)00371-1","article-title":"Gating of auditory P50 in schizophrenics: unique effects of clozapine","volume":"40","author":"Nagamoto","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib125","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1523\/JNEUROSCI.23-37-11554.2003","article-title":"Assembly of alpha 4 beta 2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons","volume":"23","author":"Nashmi","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib126","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1096-8628(19980907)81:5<361::AID-AJMG3>3.0.CO;2-W","article-title":"No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families","volume":"81","author":"Neves-Pereira","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib127","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha 7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2008.01.066","article-title":"Sensory gating in young children with autism: relation to age, IQ, and EEG gamma oscillations","volume":"434","author":"Orekhova","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0166-2236(95)93887-4","article-title":"Evolutionary history of the ligand-gated ion-channel superfamily of receptors","volume":"18","author":"Ortells","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-4632.2011.05205.x","article-title":"Smoking and the skin","volume":"51","author":"Ortiz","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib131","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib132","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(25)20464-5","article-title":"An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment","volume":"258","author":"Pauly","year":"1991","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","article-title":"Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"23","author":"Pavlov","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib134","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/eji.201040540","article-title":"Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis","volume":"40","author":"Pena","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0022-3565(24)38304-1","article-title":"Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies","volume":"289","author":"Perry","year":"1999","journal-title":"J.\u00a0Pharm. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib136","first-page":"398","article-title":"Alpha 7 nicotinic receptor stimulation modifies cytokine production and alpha 7 nAChR expression in bone marrow-derived dendritic cells","volume":"18","author":"Pinheiro","year":"2011","journal-title":"Neuroimmunomod"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib137","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09146","article-title":"Functional impact of global rare copy number variation in autism spectrum disorders","volume":"466","author":"Pinto","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib138","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","article-title":"Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood","volume":"35","author":"Pocivavsek","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib139","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bcp.2013.06.027","article-title":"Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice","volume":"86","author":"Quik","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib140","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.mp.4001140","article-title":"The-2 bp deletion in exon 6 of the \u2018alpha 7-like\u2019 nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit","volume":"7","author":"Raux","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib141","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.nbd.2005.01.017","article-title":"Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus","volume":"19","author":"Ray","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib142","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/geno.2002.6694","article-title":"A\u00a03-Mb map of a large segmental duplication overlapping the alpha 7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14","volume":"79","author":"Riley","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib143","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<196::AID-AJMG15>3.0.CO;2-4","article-title":"Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families","volume":"96","author":"Riley","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib144","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","article-title":"Cholinergic control of inflammation","volume":"265","author":"Rosas-Ballina","year":"2009","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.2012.12070940","article-title":"Perinatal choline effects on neonatal pathophysiology related to later schizohrenia risk","volume":"170","author":"Ross","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib146","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1469-7610.2009.02187.x","article-title":"Research Review: cholinergic mechanisms, early brain development, and risk for schizophrenia","volume":"51","author":"Ross","year":"2010","journal-title":"J.\u00a0Child Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib147","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/dna.2012.1880","article-title":"Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy","volume":"32","author":"Rozycka","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib148","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.2007.01141.x","article-title":"P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia","volume":"117","author":"Sanchez-Morla","year":"2008","journal-title":"Acta Psych. Scand."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib149","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.2007.07101573","article-title":"No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics","volume":"165","author":"Sanders","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib151","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1073\/pnas.071540198","article-title":"Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores","volume":"98","author":"Sharma","year":"2001","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib152","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/aps.2009.64","article-title":"Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system","volume":"30","author":"Shen","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12031-012-9719-3","article-title":"Functional alpha 7 nicotinic ACh receptors on astrocytes in rat hippocampal CA1 slices","volume":"48","author":"Shen","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib154","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0920-9964(03)80395-X","article-title":"Clozapine and olanzapine improve insufficient inhibitory processing of the P20-N40 auditory evoked potential evidence for a nicotinic mechanism","volume":"60","author":"Simosky","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib156","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2006.08.023","article-title":"Antipsychotic clozapine inhibits the function of alpha(7)-nicotinic acetylcholine receptors","volume":"52","author":"Singhal","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.07.041","article-title":"A\u00a02-base pair deletion polymorphism in the partial duplication of the alpha 7 nicotinic acetylcholine gene ( CHRFAM7A ) on chromosome 15q14 is associated with schizophrenia","volume":"1291","author":"Sinkus","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib158","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.physbeh.2010.11.007","article-title":"The alpha 7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype","volume":"104","author":"Sinkus","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib159","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2174\/092986706777935203","article-title":"Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation","volume":"13","author":"Sivaprakasam","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.schres.2009.02.001","article-title":"Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder","volume":"110","author":"Smith","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib161","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1095\/biolreprod.102.011163","article-title":"Evidence suggesting that the mouse sperm acrosome reaction initiated by the zona pellucida involves an alpha 7 nicotinic acetylcholine receptor","volume":"68","author":"Son","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib162","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1254\/jphs.FM0070091","article-title":"Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy","volume":"106","author":"Song","year":"2008","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib163","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07229","article-title":"Large recurrent microdeletions associated with schizophrenia","volume":"455","author":"Stefansson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YPG.0b013e32834c0c33","article-title":"Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia","volume":"22","author":"Stephens","year":"2012","journal-title":"Psychiatr. Gen."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2008.12.017","article-title":"Association of the 5'-upstream regulatory region of the \u03b17 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia","volume":"109","author":"Stephens","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0091-3057(01)00523-8","article-title":"Chronic corticosterone treatment alters sensory gating in C3H mice","volume":"69","author":"Stevens","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib167","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature07239","article-title":"Rare chromosomal deletions and duplications increase risk of schizophrenia","volume":"455","author":"Stone","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib168","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jnr.23160","article-title":"3- (2,4-dimethoxy)benzylidene -anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through alpha 7 nicotinic acetylcholine receptor stimulation in rats","volume":"91","author":"Suzuki","year":"2013","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib169","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1523\/JNEUROSCI.4626-11.2012","article-title":"Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders","volume":"32","author":"Tao","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib170","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/gb-2004-6-1-r4","article-title":"Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels","volume":"6","author":"Tasneem","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib171","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1212\/WNL.51.1_Suppl_1.S30","article-title":"Development of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease","volume":"51","author":"Taylor","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib172","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1399-5618.2011.00961.x","article-title":"Hippocampal alpha 7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder","volume":"13","author":"Thomsen","year":"2011","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib173","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopsych.2010.07.004","article-title":"Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia","volume":"69","author":"Tregellas","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib174","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ajmg.1550","article-title":"Examination of genetic linkage of chromosome 15 to schizophrenia in a large veterans affairs cooperative study sample","volume":"105","author":"Tsuang","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib175","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1016\/S0006-3223(00)00492-3","article-title":"A\u00a0genome scan using a pharmacogenetic approach indicates a susceptibility locus for BD on 15q14","volume":"47","author":"Turecki","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib176","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1152\/jn.00943.2002","article-title":"Regulation of neuronal function by choline and 4OH-GTS-21 through alpha 7 nicotinic receptors","volume":"89","author":"Uteshev","year":"2003","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib177","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.24470","article-title":"The alpha 7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation","volume":"60","author":"van Maanen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib178","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0896-6273(92)90301-S","article-title":"Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca++","volume":"8","author":"Vijayaraghavan","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib179","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-5728(02)00057-7","article-title":"Expression of an alpha 7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes","volume":"126","author":"Villiger","year":"2002","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajmg.a.30004","article-title":"Psychotic disorders in Prader-Willi syndrome","volume":"127A","author":"Vogels","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib181","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bcp.2013.04.001","article-title":"Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex","volume":"85","author":"Wallace","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib182","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bcp.2011.06.034","article-title":"Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease","volume":"82","author":"Wallace","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib183","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib184","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"Beta-amyloid(1-42) binds to alpha 7 nicotinic acetylcholine receptor with high affinity \u2013 implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/jnc.12436","article-title":"Activation of alpha 7-containing nicotinic receptors on astrocytes triggers AMPA receptor recruitment to glutamatergic synapses","volume":"127","author":"Wang","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib186","doi-asserted-by":"crossref","first-page":"26451","DOI":"10.1074\/jbc.M114.582858","article-title":"The duplicated \u03b17 subunits assemble and form functional nicotinic receptors with the full-length \u03b17","volume":"289","author":"Wang","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib187","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-4328(00)00199-6","article-title":"Neuronal nicotinic acetylcholine receptors: from the gene to the disease","volume":"113","author":"Weiland","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.neuropharm.2015.02.006_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084059","article-title":"CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's disease","volume":"8","author":"Weng","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib189","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.11m07522","article-title":"A\u00a0randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder","volume":"73","author":"Williams","year":"2012","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.ajp.2011.11060822","article-title":"Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3","volume":"169","author":"Williams","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.006_bib191","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3528-14.2015","article-title":"Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus","author":"Xiao","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib192","doi-asserted-by":"crossref","first-page":"12078","DOI":"10.1073\/pnas.1307849110","article-title":"Nicotinic \u03b17 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib193","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1093\/hmg\/ddr357","article-title":"15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain","volume":"20","author":"Yasui","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib194","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.nutr.26.061505.111156","article-title":"Choline: critical role during fetal development and dietary requirements in adults","volume":"26","author":"Zeisel","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.neuropharm.2015.02.006_bib195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1176\/appi.ajp.2012.11081289","article-title":"Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia","volume":"169","author":"Zhang","year":"2012","journal-title":"Am. J. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:35:33Z","timestamp":1747665333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":195,"alternative-id":["S0028390815000532"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}